Top

Published in:

01-07-2016 | Topic Review

Spinal cord ependymoma: a review of the literature and case series of ten patients

Authors: Emma Celano, Arsalaan Salehani, James G. Malcolm, Erik Reinertsen, Constantinos G. Hadjipanayis

Published in: Journal of Neuro-Oncology | Issue 3/2016

Abstract

Spinal cord ependymoma (SCE) is a rare tumor that is most commonly low-grade. Complete surgical resection has been established as first-line treatment and can be curative. However, SCEs tend to recur when complete tumor resection is not possible. Evidence supporting the use of adjuvant radiation and chemotherapy is not definitive. We review the most recent literature on SCE covering a comprehensive range of topics spanning the biology, presentation, clinical management, and outcomes. In addition, we present a case series of ten SCE patients with the goal of contributing to existing knowledge of this rare disease.

Chamberlain MC (2003) Ependymomas. Curr Neurol Neurosci Rep 3:193–199CrossRefPubMed

Schwartz TH, McCormick PC (2000) Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 47:211–218CrossRefPubMed

Payne NS, McDonald JV (1973) Rupture of spinal cord ependymoma. J Neurosurg 39:662–665CrossRefPubMed

Tonogai I, Sakai T, Tezuka F, Goda Y, Takata Y, Higashino K, Sairyo K (2014) Spontaneous rupture and hemorrhage of myxopapillary ependymoma of the filum terminale: a case report and literature review. J Med Investig 61:430–435CrossRef

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedPubMedCentral

Perry A, Prayson RA (2012) Glial and Glioneuronal Tumors. In: Prayson RA (ed) Neuropathology, 2nd edn. Elsevier Inc., Philadelphia, pp 461–512

Engelhard HH, Villano JL, Porter KR, Stewart AK, Barua M, Barker FG, Newton HB (2010) Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina. J Neurosurg Spine 13:67–77CrossRefPubMed

Ogden AT, Schwartz TH, Mccormick PC (2011) Spinal cord tumors in adults. In: Winn HR (ed) Youmans Neurol Surgery Vol 2, 6th edn. Elsevier Saunders, Philadelphia, pp 3131–3143CrossRef

Klekamp J (2015) Spinal ependymomas. Part 1: Intramedullary ependymomas. Neurosurg Focus 39:E6CrossRefPubMed

10.

Raghunathan A, Wani K, Armstrong TS et al (2013) Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol 23:584–594CrossRefPubMed

11.

Smirniotopoulos JG, Brain E (2013) Non-astrocytic gliomas. In: Ellison D, Love S (eds) Neuropathology, 3rd edn. Elsevier Inc., Philadelphia, pp 729–742

12.

Oh MC, Kim JM, Kaur G, Safaee M, Sun MZ, Singh A, Aranda D, Molinaro AM, Parsa AT (2013) Prognosis by tumor location in adults with spinal ependymomas. J Neurosurg Spine 18:226–235CrossRefPubMed

13.

Yang I, Nagasawa DT, Kim W, Spasic M, Trang A, Lu DC, Martin NA (2012) Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas. J Clin Neurosci 19:779–785CrossRefPubMedPubMedCentral

14.

Oh MC, Tarapore PE, Kim JM, Sun MZ, Safaee M, Kaur G, Aranda D, Parsa AT (2013) Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci 20(10):1390–1397CrossRefPubMedPubMedCentral

15.

Boström A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Boström JP, Schramm J, Simon M (2011) Surgery for spinal cord ependymomas: outcome and prognostic factors. Neurosurgery 68:302–309CrossRefPubMed

16.

Abdel-Wahab M, Etuk B, Palermo J et al (2006) Spinal cord gliomas: A multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys 64:1060–1071CrossRefPubMed

17.

Nagasawa DT, Smith ZA, Cremer N, Fong C, Lu DC, Yang I (2011) Complications associated with the treatment for spinal ependymomas. Neurosurg Focus 31:E13CrossRefPubMed

18.

Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, Sayegh ET, Aranda D, Parsa AT (2013) Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro Oncol 15:208–215CrossRefPubMed

19.

Jallo GI, Zagzag D, Epstein FJ (1996) Intramedullary subependymoma of the cervical spinal cord. Neurosurgery 38:251–257CrossRefPubMed

20.

Tarapore PE, Modera P, Naujokas A et al (2013) Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients. Neurosurgery 73:247–255 discussion 255 CrossRefPubMed

21.

Klekamp J (2015) Spinal ependymomas. Part 2: Ependymomas of the filum terminale. Neurosurg Focus 39:E7CrossRefPubMed

22.

Bagley CA, Wilson S, Kothbauer KF, Bookland MJ, Epstein FJ, Jallo GI (2009) Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev 32:321–334 discussion 334 CrossRefPubMed

23.

Mineura K, Shioya H, Kowada M, Ogawa T, Hatazawa J, Uemura K (1997) Subependymoma of the septum pellucidum: characterization by PET. J Neurooncol 32:143–147CrossRefPubMed

24.

Koeller KK, Rosenblum SR, Morrison AL (2000) Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 20:1721–1749CrossRefPubMed

25.

Yuh EL, Barkovich AJ, Gupta N (2009) Imaging of ependymomas: MRI and CT. Child’s Nerv Syst 25:1203–1213CrossRef

26.

Kahan H, Sklar EM, Post MJ, Bruce JH (1996) MR characteristics of histopathologic subtypes of spinal ependymoma. Am J Neuroradiol 17:143–150PubMed

27.

Chang U-K, Choe W-J, Chung S-K, Chung C-K, Kim H-J (2002) Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults. J Neurooncol 57:133–139CrossRefPubMed

28.

Lee S-H, Chung CK, Kim CH, Yoon SH, Hyun S-J, Kim K-J, Kim E-S, Eoh W, Kim H-J (2013) Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. Neuro Oncol 15:921–929CrossRefPubMedPubMedCentral

29.

Nakamura M, Ishii K, Watanabe K, Tsuji T, Takaishi H, Matsumoto M, Toyama Y, Chiba K (2008) Surgical treatment of intramedullary spinal cord tumors: prognosis and complications. Spinal Cord 46:282–286CrossRefPubMed

30.

Volpp PB, Han K, Kagan AR, Tome M (2007) Outcomes in treatment for intradural spinal cord ependymomas. Int J Radiat Oncol Biol Phys 69:1199–1204CrossRefPubMed

31.

Peker S, Ozgen S, Ozek MM, Pamir MN (2004) Surgical treatment of intramedullary spinal cord ependymomas: can outcome be predicted by tumor parameters? J Spinal Disord Tech 17:516–521CrossRefPubMed

32.

Sakai Y, Matsuyama Y, Katayama Y et al (2009) Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery. Spine 34(15):1619–1624CrossRefPubMed

33.

Halvorsen CM, Kolstad F, Hald J et al (2010) Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery 67:1622–1631 discussion 1631 CrossRefPubMed

34.

Nakamura M, Ishii K, Watanabe K, Tsuji T, Matsumoto M, Toyama Y, Chiba K (2009) Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina. Spine 34(21):E756–E760CrossRefPubMed

35.

Abdulaziz M, Mallory GW, Bydon M et al (2015) Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity. Neurosurg Focus 39:1–7CrossRef

36.

Clover LL, Hazuka MB, Kinzie JJ (1993) Spinal cord epenymomas treated with surgery and radiation therapy: a review of 11 cases. Am J Clin, Oncol

37.

Isaacson SR (2000) Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol 47:231–238CrossRefPubMed

38.

Merchant TE, Boop FA, Kun LE, Sanford RA (2008) A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys 71:87–97CrossRefPubMed

39.

Amsbaugh MJ, Grosshans DR, McAleer MF, Zhu R, Wages C, Crawford CN, Palmer M, De Gracia B, Woo S, Mahajan A (2012) Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys 83:1419–1424CrossRefPubMed

40.

Ryu SI, Kim DH, Chang SD (2003) Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus 15:E10CrossRefPubMed

41.

Chamberlain MC (2002) Etoposide for recurrent spinal cord ependymoma. Neurology 58:1310–1311CrossRefPubMed

42.

Chamberlain MC (2002) Salvage chemotherapy for recurrent spinal cord ependymona. Cancer 95:997–1002CrossRefPubMed

43.

Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN (1996) Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39(1):135–140CrossRefPubMed

44.

Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A (2005) Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. Mod Pathol 18:991–997CrossRefPubMed

45.

Santi M, Quezado M, Ronchetti R, Rushing EJ (2005) Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization. J Neurooncol 72:25–28CrossRefPubMed

46.

Suzuki S, Iwaki T (2000) Amplification and overexpression of mdm2 gene in ependymomas. Mod Pathol 13:548–553CrossRefPubMed

47.

Manasa LP, Uppin MS, Sundaram C (2012) Correlation of p53 and KI-67 expression with grade and subtype of ependymoma. Indian J Pathol Microbiol 55:308–313CrossRefPubMed

48.

Rudà R, Gilbert MR, Soffietti R (2008) Ependymomas of the adult: molecular biology and treatment. Curr Opin Neurol 21:754–761CrossRefPubMed

49.

Gilbertson RJ, Bentley L, Hernan R et al (2002) ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 8:3054–3064PubMed

50.

Kong L-Y, Wei J, Haider AS et al (2014) Therapeutic targets in subependymoma. J Neuroimmunol 277:168–175CrossRefPubMed

51.

Zhang S, Wang X, Zhang Z, Chen Y (2008) Tanycytic ependymoma arising from the right lateral ventricle: A case report and review of the literature. Neuropathology 28:427–432CrossRefPubMed

Title: Spinal cord ependymoma: a review of the literature and case series of ten patients
Authors: Emma Celano
Arsalaan Salehani
James G. Malcolm
Erik Reinertsen
Constantinos G. Hadjipanayis
Publication date: 01-07-2016
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-016-2135-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Spinal cord ependymoma: a review of the literature and case series of ten patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Exploratory study of the effect of brain tumors on the default mode network

Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors

Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures

State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature

Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study

Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas